Conceivably, activation of TRPV1 may alleviate cardiometabolic organs dysfunction, including ameliorating atherosclerosis, cardiac hypertrophy, non-alcoholic fatty liver, and stroke risk (Figure 2). This evidence concerns the gene TRPV1 and cardiac hypertrophy.